Found 8 matching trials
To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors
PHASE1This is a Phase I open, multi-center, first-in-human study evaluating JSKN0...
Location
Fujian Cancer Hospital
JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors
PHASE1This is a Phase I, open-label, multicenter, first-in-human study to evaluat...
Location
Scientia Clinical Research Ltd
JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer
PHASE1This is a multicenter, open-label, Phase Ib/II randomized study designed to...
Location
Fudan University Shanghai Cancer center
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
PHASE1This is a Phase Ib clinical study conducted in China to evaluate the treatm...
Location
Sun Yat-sen University Cancer Center
A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care
PHASE3Primary Endpoint of this Study:
To compare Progression-Free Survival (PFS)...
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients
PHASE2This study aims to evaluate the efficacy and safety of JSKN016 combined wit...
Location
Shanghai Pulmonary Hospital
Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung CanceοΌ a Phase II Clinical Study
PHASE2This is a Phase II clinical study conducted in China to evaluate the treatm...
Location
Multiple Locations
Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer
PHASE1This study aims to evaluate the safety and effectiveness of JSKN016 in comb...
Location
Fudan University Shanghai Cancer center